Effects of synthetic retinoid Am80 on iodide-induced autoimmune thyroiditis in nonobese diabetic mice

Cellular Immunology

Volumn 270, Issue 1, 2011, Pages 1-4

  Morohoshi, Kazuki ^a   Yoshida, Katsumi ^a   Nakagawa, Yoshinori ^a   Hoshikawa, Saeko ^a   Ozaki, Hiroshi ^a   Takahashi, Yurie ^a   Ito, Sadayoshi ^a   Mori, Kouki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Am80; Hashimoto's thyroiditis; Iodide; Nonobese diabetic mouse; Retinoid

Indexed keywords

GAMMA INTERFERON; IODIDE; TAMIBAROTENE; THYROGLOBULIN ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ARTICLE; AUTOIMMUNE THYROIDITIS; CELL PROLIFERATION; DRUG EFFECT; DRUG POTENCY; EXPERIMENTAL MODEL; FEMALE; HASHIMOTO DISEASE; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; THYROID GLAND;

ADMINISTRATION, ORAL; ANIMALS; AUTOANTIBODIES; BENZOATES; DIABETES MELLITUS, TYPE 1; DRUG INTERACTIONS; INTERFERON-GAMMA; LYMPHOCYTE COUNT; MICE; MICE, INBRED NOD; RETINOIDS; SPLEEN; T-LYMPHOCYTES; TETRAHYDRONAPHTHALENES; THYROIDITIS, AUTOIMMUNE;

ANIMALIA; MUS;

EID: 79959813868     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2011.05.005     Document Type: Article

References (20)

1. Mark M., Ghyselinck N.B., Chambon P. Function of retinoic acid receptors during embryonic development. Nucl. Recept. Signal. 2009, 7:e002.
2. Kang B.Y., Chung S.W., Kim S.H., Kang S.N., Choe Y.K., Kim T.S. Retinoid-mediated inhibition of interleukin-12 production in mouse macrophages suppresses Th1 cytokine profile in CD4+ T cells. Br. J. Pharmacol. 2000, 130:581-586.
3. Iwata M., Eshima Y., Kagechika H. Retinoic acids exert direct effects on T cells to suppress Th1 development and enhance Th2 development via retinoic acid receptors. Int. Immunol. 2003, 15:1017-1025.
4. Mucida D., Park Y., Kim G., Turovskaya O., Scott I., Kronenberg M., Cheroutre H. Reciprocal Th17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007, 317:256-260.
5. Schambach F., Schupp M., Lazar M.A., Reiner S.L. Activation of retinoic acid receptor-α favours regulatory T cell induction at the expense of IL-17-secreting T helper cell differentiation. Eur. J. Immunol. 2007, 37:2396-2399.
6. Elias K.M., Laurence A., Davidson T., Stephens G., Kanno Y., Shevach E.M., O'Shea J.J. Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood 2008, 111:1013-1020.
7. Ishido M., Shudo K. Oral administration of synthetic retinoid Am80 inhibits the development of type 1 diabetes in non-obese diabetic (NOD) mice. Biol. Pharm. Bull. 2009, 32:157-159.
8. Van Y.-H., Lee W.-H., Ortiz S., Lee M.-H., Qin H.-J., Liu C.-P. All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-γ-producing T-cells without affecting Th17 cells. Diabetes 2009, 58:146-155.
9. Kuwabara K., Shudo K., Hori Y. Novel synthetic retinoic acid inhibits rat collagen arthritis and differentially affects serum immunoglobulin subclass levels. FEBS Lett. 1996, 378:153-156.
10. Sato A., Watanabe K., Kaneko K., Murakami Y., Ishido M., Miyasaka N., Nanki T. The effect of synthetic retinoid, Am80, on T helper cell development and antibody production in murine collagen-induced arthritis. Mod. Rheumatol. 2010, 20:244-251.
11. Xiao S., Jin H., Korn T., Liu S.M., Oukka M., Lim B., Kuchroo V.K. Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-β-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J. Immunol. 2008, 181:2277-2284.
12. Klemann C., Raveney B.J.E., Klemann A.K., Ozawa T., von Hörsten S., Shudo K., Oki S., Yamamura T. Synthetic retinoid AM80 inhibits Th17 cells and ameliorates experimental autoimmune encephalomyelitis. Am. J. Pathol. 2009, 174:2234-2245.
13. Weetman A.P. Cellular immune responses in autoimmune thyroid disease. Clin. Endocrinol. 2004, 61:405-413.
14. Jansz A., Flad H.D., Koffler D., Miescher P.A. The effect of vitamin A on experimental immune thyroiditis. Int. Arch. Allergy Appl. Immunol. 1967, 31:69-77.
15. Damotte D., Colomb E., Cailleau C., Brousse N., Charreire J., Carnaud C. Analysis of susceptibility of NOD mice to spontaneous and experimentally induced thyroiditis. Eur. J. Immunol. 1997, 27:2854-2862.
16. Tani J.-I., Mori K., Hoshikawa S., Nakazawa T., Satoh J., Nakagawa Y., Ito S., Yoshida K. Prevention of lymphocytic thyroiditis in iodide-treated non-obese diabetic mice lacking interferon regulatory factor-1. Eur. J. Endocrinol. 2002, 147:809-814.
17. Ishido M., Kagechika H. Tamibarotene. Drugs of Today 2007, 43:563-568.
18. Kong Y., David C.S., Giraldo A.A., Elrehewy M., Rose N.R. Regulation of autoimmune response to mouse thyroglobulin: influence of H-2D-end genes. J. Immunol. 1979, 123:15-18.
19. Champion B.R., Rayner D.C., Byfield P.G., Page K.R., Chan C.T., Roitt I.M. Critical role of iodination for T cell recognition of thyroglobulin in experimental murine thyroid autoimmunity. J. Immunol. 1987, 139:3665-3670.
20. Miller S.C., Kearney S.L. Effect of in vivo administration of all trans-retinoic acid on the hemopoietic cell populations of the spleen and bone marrow: profound strain differences between A/J and C57BL/6J mice. Lab. Anim. Sci. 1998, 48:74-80.